Gerhard Ecker

Council approves the launch of MedChemComm

In analogy to Chemical Communications, MedChemComm will focus on preliminary articles in communications format. Presenting new ideas and concepts in the area of Medicinal Chemistry, MedChemcomm will include new studies related to biologically-active chemical or biochemical entities that can act as pharmacological agents with therapeutic potential or relevance. The journal will be suitable for readers from both academia and industry, conducting research in the field of medicinal chemistry, drug discovery, pharmacology and pharmaceutical research. This will include traditional areas of the chemical sciences together with topics at the interface with biology and physics. The journal will act globally with regional offices in Europe, Asia and Northern America. The first issue is expected by mid of next year..

By Gerhard Ecker


Gabriele Costantino
Univ. Parma, IT

Editorial Committee

Erden Banoglu
Gazi Univ., TR

Jordi Mestres

Wolfgang Sippl
Univ. Halle-Wittenberg, DE

Kristian Stromgaard
Univ. Copenhagen, DK

Mark Lansdell
Pfizer, UK

Executive Committee

Gerhard Ecker President
Roberto Pellicciari Past-Pres.
Koen Augustyns Secretary
Rasmus P.Clausen Treasurer
Javier Fernandez Member
Mark Bunnage Member
Peter Matyus Member

For more information please contact